We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
From 1 April 2023, women in England will be able to access cheaper hormone replacement therapy (HRT) to help with menopause symptoms.
First published during the 2022 to 2024 Sunak Conservative government
The EU has taken steps to give manufacturers more time to get certain medical devices certified under the EU Medical Devices Regulation (EU MDR).
Four life sciences companies from across the UK will benefit from the first tranche of Life Sciences Innovative Manufacturing Fund (LSIMF) grants.
Sir Hugh Taylor has been appointed as Chief Negotiations Adviser for the voluntary scheme for branded medicines pricing and access (VPAS).
The legislative changes will help to make the UK one of the best countries in the world to conduct clinical research for patients and researchers.
The UK Government has named two leaders in dementia research to spearhead the ambitious national Mission to tackle dementia.
Around 400,000 women across England will get better access to menopause support - saving hundreds of pounds and making treatment more accessible.
The MHRA’s UK Stem Cell Bank is one of only two places in the world to test this technology.
HM Treasury has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) will receive £10 million to help bring innovative new medicines and medical technologies to UK patients more quickly.
Following a comprehensive scientific safety review of the latest available data on the safety of pholcodine, together with advice from the independent Commission on Human Medicines, it has been concluded that the potential r…
Three members of an organised criminal gang were sentenced today (13 March 2023) at Stoke Crown Court to jail after pleading guilty to offences relating to the illegal sale of more than three million doses of prescription-on…
Charges for NHS prescriptions, wigs and fabric supports.
Update to the Life Sciences Council Joint Statement on Medical Devices Regulatory Reform.
The MHRA is reviewing the evidence relating to the very rare risk of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) associated with medicines containing pseudoeph…
Tens of thousands of patients across England to get quicker access to life-saving tests as 19 additional community diagnostic centres (CDCs) to open this year.
Tens of thousands of elderly and vulnerable people will receive tailored support at home as part of a new NHS plan to improve waiting times for emergency care.
The Minister of State at DHSC has responded to recommendations made by the Regulatory Horizons Council (RHC) on the regulation of medical devices.
The establishment of a regulatory framework for POC manufacturing would bring a range of benefits to patients, healthcare professionals and innovators.
The ECDRP has been extended to 31 December 2023. From 1 January 2024, a new international recognition framework will be in place.
Horizon Scanning in the MHRA Innovation Accelerator includes a focus on the identification of Actionable Horizon Scanning Signals, but what are these, and how and why do we identify them?
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).